A patient with worsening preeclampsia is being evaluated for potential HELLP syndrome. Given the current clinical scenario, which nursing intervention is the most critical in preventing maternal and fetal complications?

A) Administer magnesium sulfate to prevent seizures.

B) Increase oral fluids to manage potential dehydration.

C) Encourage ambulation to reduce the risk of thrombosis.

D) Provide a high-protein diet to improve liver function.

A nurse is caring for a patient with severe preeclampsia and suspected HELLP syndrome. The patient's blood pressure remains elevated at 162/112 mmHg despite administration of Labetalol. Which of the following actions should the nurse prioritize to address the patient's condition?

A) Administer magnesium sulfate to prevent seizures

B) Increase the dosage of Labetalol to further reduce blood pressure

C) Prepare the patient for immediate delivery to address maternal and fetal complications

D) Initiate continuous fetal monitoring to assess for fetal distress

A patient with suspected HELLP syndrome is being prepared for an emergency cesarean section due to deteriorating maternal health. What is the nurse's priority intervention to perform before the procedure?

A) Administer magnesium sulfate to prevent seizures.

B) Monitor fetal heart rate continuously.

C) Ensure consent forms are signed and documented.

D) Prepare for blood transfusion due to low platelet count.

A patient with suspected HELLP syndrome is being prepared for an emergency cesarean section. Given the patient's current condition, which nursing intervention is the priority to ensure maternal safety?

D) Monitor the patient for signs of magnesium toxicity due to magnesium sulfate infusion.

A) Administer additional doses of intravenous Labetalol to manage hypertension.

B) Prepare the patient for a blood transfusion due to decreased platelet count.

C) Initiate continuous fetal heart monitoring to assess fetal well-being.

D) Monitor the patient for signs of magnesium toxicity due to magnesium sulfate infusion.

A patient with preeclampsia is receiving magnesium sulfate therapy when she begins to exhibit signs of magnesium toxicity. Which of the following interventions should the nurse prioritize to address this complication?

B) Administer calcium gluconate intravenously

A) Increase the rate of magnesium sulfate infusion

B) Administer calcium gluconate intravenously

C) Encourage deep breathing exercises to improve respiratory rate

D) Monitor blood pressure and prepare for emergency delivery

A nurse is caring for a patient with severe preeclampsia who is receiving magnesium sulfate. The patient exhibits a decreased respiratory rate of 10 breaths per minute and diminished deep tendon reflexes. What is the nurse's priority intervention?

B) Administer calcium gluconate.

A) Increase the magnesium sulfate infusion rate.

B) Administer calcium gluconate.

C) Place the patient in Trendelenburg position.

D) Increase the patient's fluid intake to enhance elimination.

A postpartum patient with a history of severe preeclampsia and recent cesarean section is showing signs of pulmonary edema, elevated blood pressure, tachycardia, and respiratory distress. Which nursing intervention is the priority to address her current symptoms?

D) Administer furosemide as ordered to manage pulmonary edema.

A) Administer oxygen via nasal cannula to improve oxygenation.

B) Increase the dose of antihypertensive medications to lower blood pressure.

C) Prepare for possible intubation due to respiratory distress.

D) Administer furosemide as ordered to manage pulmonary edema.

A postpartum patient who underwent a cesarean section is experiencing elevated blood pressure, tachycardia, and shortness of breath. Auscultation reveals crackles in the lung bases, and the patient is diaphoretic and anxious. Laboratory findings show decreasing platelet levels and elevated liver enzymes. Based on these clinical indicators, what is the priority nursing intervention?

A) Administer supplemental oxygen and prepare for possible intubation.

B) Monitor urine output closely to assess the effectiveness of diuretic therapy.

C) Initiate seizure precautions due to risk of eclampsia.

D) Prepare for immediate blood transfusion to address thrombocytopenia.

A postpartum patient who underwent a cesarean section presents with neurological changes, persistent hypertension, and has been diagnosed with mild cerebral edema. Which nursing intervention is the highest priority to prevent further complications?

A) Administer magnesium sulfate as ordered to prevent seizures.

B) Increase fluid intake to ensure adequate renal perfusion.

C) Encourage early ambulation to prevent thromboembolism.

D) Administer antihypertensives to maintain blood pressure within normal limits.

A post-cesarean section patient with a history of severe preeclampsia is experiencing neurological changes, including lethargy, confusion, and episodes of unresponsiveness. Her blood pressure is 165/110 mmHg, and she has mild cerebral edema on CT scan. Magnesium sulfate therapy is initiated. What is the primary nursing intervention to ensure the safety and efficacy of this treatment?

A) Monitor deep tendon reflexes and respiratory rate.

B) Increase fluid intake to promote renal perfusion.

C) Administer furosemide to reduce cerebral edema.

D) Position the patient in Trendelenburg to lower blood pressure.

Preeclampsia - Nursing Case Study

Pathophysiology

• Primary mechanism: Preeclampsia primarily arises from abnormal placentation, where the trophoblastic invasion of the uterine spiral arteries is inadequate. This results in high-resistance blood flow and placental ischemia, leading to the release of antiangiogenic factors into the maternal circulation.

• Secondary mechanism: The imbalance between proangiogenic and antiangiogenic factors disrupts endothelial function, causing widespread vasoconstriction and increased vascular permeability. This leads to hypertension and proteinuria, hallmark features of preeclampsia.

• Key complication: If unaddressed, these vascular changes can progress to multi-organ damage, including renal, hepatic, and neurological complications, increasing the risk for both maternal and fetal morbidity and mortality.

Patient Profile

Demographics:

29-year-old female, school teacher

History:

• Key past medical history: History of hypertension, first pregnancy

• Current medications: Prenatal vitamins, Labetalol 200 mg twice daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe headache and visual disturbances

• Key symptoms: Swelling in hands and feet, upper right abdominal pain, nausea

• Vital signs: Blood pressure 160/110 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

As the clinical team conducts an initial assessment, further details emerge that raise concern for potential complications. The patient's severe headache and visual disturbances prompt a neurological evaluation, revealing brisk reflexes and the presence of clonus, suggesting potential for eclampsia. A urine dipstick test confirms significant proteinuria, with a reading of +3, consistent with worsening preeclampsia. Laboratory results indicate elevated liver enzymes (AST 85 U/L, ALT 90 U/L) and low platelet count (120,000/mm³), raising the suspicion of HELLP syndrome, a severe form of preeclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count.

The patient's blood pressure remains elevated despite administration of Labetalol, recorded at 162/112 mmHg, underscoring the need for more aggressive blood pressure management and possibly escalating to intravenous antihypertensive therapy. The upper right abdominal pain, coupled with the altered liver function tests, suggests hepatic involvement, which requires close monitoring for signs of hepatic rupture or subcapsular hematoma. Given these findings, the medical team discusses the necessity of preparing for potential preterm delivery to prevent further maternal and fetal complications.

These developments necessitate a reevaluation of the patient's management plan. The obstetrics team, in consultation with maternal-fetal medicine specialists, considers corticosteroid administration to enhance fetal lung maturity in anticipation of preterm delivery, balancing the risks and benefits. The care team also plans for continuous fetal monitoring to assess for any signs of fetal distress, ensuring both maternal and fetal well-being are prioritized as they navigate this critical juncture in the patient's care.

Section 2

As the medical team continues to monitor the patient, her condition evolves, prompting a shift in clinical priorities. Approximately two hours after the initial interventions, the patient's vital signs reveal further hypertensive urgency, with blood pressure readings now at 170/115 mmHg. Despite the administration of intravenous Labetalol, her blood pressure remains unresponsive, indicating the need for an alternative or additional antihypertensive strategy. The decision is made to initiate a magnesium sulfate infusion to address the risk of seizure activity associated with eclampsia, given her neurological symptoms and the presence of clonus.

Concurrently, the patient's abdominal pain intensifies, and she reports increased discomfort and tenderness in the right upper quadrant. A repeat laboratory panel demonstrates a further decline in platelet count to 100,000/mm³ and a rise in liver enzymes, with AST climbing to 110 U/L and ALT to 120 U/L. These findings heighten the team's concern for progression of HELLP syndrome. An abdominal ultrasound is urgently ordered to assess the liver for any signs of rupture or hematoma, which could signify a life-threatening complication. The ultrasound results reveal mild hepatomegaly but no immediate evidence of hepatic rupture, allowing the team to proceed with cautious but urgent management.

In light of these developments, the decision is made to expedite delivery. The maternal-fetal medicine specialists and obstetrics team agree that the risks of continuing the pregnancy outweigh the benefits, especially with the rapid deterioration of maternal health. Plans are coordinated for an emergency cesarean section, with neonatal and anesthesiology teams on standby to ensure comprehensive support. The administration of corticosteroids continues to optimize fetal outcomes, while preparation for neonatal intensive care is underway to address the challenges of preterm birth. This proactive approach underscores the importance of balancing maternal stabilization with the anticipation of complex neonatal needs, setting the stage for the next critical steps in the patient's care journey.

Section 3

As the medical team prepares for the emergency cesarean section, they continue to closely monitor the patient's status, integrating the recent clinical data to guide their interventions. Shortly after the initiation of the magnesium sulfate infusion, the patient begins to exhibit signs of magnesium sulfate toxicity. Her respiratory rate decreases to 10 breaths per minute, and deep tendon reflexes are diminished, indicating the need for immediate adjustment of the magnesium infusion rate. The team swiftly administers calcium gluconate as an antidote to counteract the toxicity, while simultaneously adjusting the infusion to a safer rate. This critical intervention stabilizes her condition, allowing the team to proceed with the planned delivery.

The patient's blood pressure remains a concern, with readings persistently elevated at 168/110 mmHg despite the addition of hydralazine to the antihypertensive regimen. This necessitates ongoing evaluation by the anesthesiology team to optimize intraoperative management and ensure maternal hemodynamic stability during the cesarean section. The patient's neurological symptoms, including headache and visual disturbances, begin to subside with the stabilization of magnesium levels, but the team remains vigilant for any signs of eclampsia or further deterioration.

As the cesarean section commences, the neonatal team is prepared for potential complications associated with preterm birth. The infant is delivered with an initial Apgar score of 6 at one minute, requiring immediate intervention for respiratory support. The neonatal team initiates positive pressure ventilation and transports the newborn to the NICU for further evaluation and management. This scenario underscores the importance of coordinated, multidisciplinary care, as both maternal and neonatal teams navigate the complexities of preeclampsia with HELLP syndrome, illustrating the critical balance of maternal and fetal health priorities in this high-risk situation.

Section 4

As the medical team continues to monitor the patient's postpartum status, they observe a change in her condition approximately two hours after the cesarean section. The patient's blood pressure remains elevated at 160/105 mmHg despite ongoing antihypertensive therapy. Notably, her heart rate has increased to 120 beats per minute, and she reports feeling increasingly short of breath. Upon auscultation, crackles are heard in her lung bases, and she appears diaphoretic and anxious. These findings suggest the development of pulmonary edema, a known complication in severe preeclampsia cases, likely exacerbated by fluid shifts and reduced oncotic pressure.

In response to these developments, the team decides to initiate diuretic therapy with furosemide to address the fluid overload, carefully balancing this intervention against the need to maintain adequate perfusion to vital organs. Additionally, they perform an arterial blood gas analysis, which reveals mild respiratory acidosis with a pH of 7.32, indicating the need for continued close monitoring of respiratory function. The team also considers the possible need for further escalation of care, such as non-invasive ventilation, should the patient's respiratory status deteriorate further.

The patient's laboratory results are reviewed, revealing a concerning trend with decreasing platelet levels now at 85,000/mm³ and liver enzymes continuing to rise, with AST at 200 IU/L and ALT at 180 IU/L. These findings indicate a progression of HELLP syndrome, necessitating the involvement of the hematology team to guide further management and prevent complications such as disseminated intravascular coagulation. The multidisciplinary team remains vigilant, coordinating efforts to stabilize the patient's condition while preparing for potential interventions, underscoring the complexity of managing severe preeclampsia and its associated complications.

Section 5

As the multidisciplinary team continues to manage the patient's condition, they observe a new complication in her clinical status. Approximately four hours post-cesarean section, the patient's neurological status begins to exhibit changes. She becomes increasingly lethargic and exhibits confusion, with episodes of unresponsiveness interspersed with agitation. A repeat assessment of her vital signs reveals persistent hypertension with blood pressure readings at 165/110 mmHg, and her heart rate remains elevated at 118 beats per minute. Given these neurological changes, along with the existing hypertension and lab abnormalities, there is a growing concern for cerebral involvement, potentially indicating the onset of eclampsia.

In light of these developments, the team prioritizes a neurologic assessment and orders an urgent CT scan of the head to rule out intracranial hemorrhage or cerebral edema. The CT scan reveals mild cerebral edema, prompting the team to initiate magnesium sulfate therapy to prevent seizures, a critical intervention in the management of preeclampsia with severe features. The patient's fluid status is closely monitored to prevent further exacerbation of cerebral edema while maintaining adequate circulation to vital organs.

The team also revisits the patient's medication regimen, ensuring optimal dosing of antihypertensives to achieve tighter blood pressure control without compromising renal perfusion. The ongoing challenge of managing her HELLP syndrome is addressed through consultation with hematology to consider potential transfusions or other interventions to stabilize her platelet count and liver function. This comprehensive approach underscores the critical need for continuous reassessment and swift adaptation of the care plan to address the evolving complications of severe preeclampsia. The patient's journey forward will depend on close monitoring and timely interventions to prevent further deterioration and ensure maternal and fetal well-being.